Coagulopathy in Trauma Patients

  • M. Lynn
  • I. Jeroukhimov
  • Y. Klein


Massive hemorrhage is a major cause of trauma-related mortality. It has been shown that uncontrolled bleeding is the second most common cause of death after central nervous system (CNS) injuries in the pre-hospital setting [l], and the first responsible for early in-hospital mortality (first 48 hours) from major trauma [2].


Trauma Patient Clotting Factor Coagulation Cascade Fibrin Clot Massive Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MacKenzie EJ, Fowler CJ (2000) Epidemiology. In: Mattox KL, Feliciano DV, Moore EE (eds) Trauma. Fourth Edition, MacGraw-Hill, New York, pp 21–39Google Scholar
  2. 2.
    Sauaia A, Moore FA, Moore EE, et al (1995) Epidemiology of trauma death: a reassessment. J Trauma 38: 185–193PubMedCrossRefGoogle Scholar
  3. 3.
    Hoyt DB, Bulger EM, Knudson MM, et al (1994) Death in the operating room: An analysis of multicenter experience. J Trauma 37: 426–432PubMedCrossRefGoogle Scholar
  4. 4.
    Rotondo MF, Zonies DH (1997) The damage control sequence and underlying logic. Surg Clin N Am 77: 761–777PubMedCrossRefGoogle Scholar
  5. 5.
    Johnson JW, Gracias VH, Schwab CW, et al (2000) Evolution in damage control for exanguinating penetrating abdominal injury. J Trauma 51: 261–269CrossRefGoogle Scholar
  6. 6.
    Moore EE (1996) Staged laparotomy for hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 172: 405PubMedCrossRefGoogle Scholar
  7. 7.
    Rotondo MF, Schwab CW, McGonigal MD, et al (1993) Damage control: an approach to improve survival in exanguinated penetrating abdominal injury. J Trauma 35: 375–382PubMedCrossRefGoogle Scholar
  8. 8.
    Patt A, McCroscey BL, Moore EE (1988) Hypothermia-induced coagulopathies in trauma. Surg Clin North Am 68: 775–785PubMedGoogle Scholar
  9. 9.
    Bell WE (1979) Physiology of the fibrinolytic enzyme system. In: Sherry S (ed) Thrombosis and Thrombolysis. Hoechst-Roussel Pharmaceuticals, Somerville, p 192Google Scholar
  10. 10.
    Eddy VA, Morris JA, Cullinane DC (2000) Hypothermia, coagulopathy, acidosis. Surg Clin North Am 80: 845–854PubMedCrossRefGoogle Scholar
  11. 11.
    Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81: 360–365PubMedGoogle Scholar
  12. 12.
    Goskowicz R (1999) The complication of massive blood transfusion. Anesth Clin North Am 17: 959–975CrossRefGoogle Scholar
  13. 13.
    Villalobos TJ, Adelson E, Borila TG (1955) Hematologic changes in hypothermic dogs. Proc Soc Exp Biol Med 89: 192–196PubMedGoogle Scholar
  14. 14.
    Hessen FA, Schmer G, Dillard DH (1980) Platelet kinetics during deep hypothermia. J Surg Res 28: 23–34CrossRefGoogle Scholar
  15. 15.
    Michelson AD, MacGregor H, Barnard MR, et al (1994) Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Hemost 71: 633–640Google Scholar
  16. 16.
    Valeri CR, Feingold H, Cassidy G, et al (1987) Hypothermia-induced reversible platelet dysfunction. Ann Surg 205: 175–181PubMedCrossRefGoogle Scholar
  17. 17.
    Reed RL, Bracey AWJ, Hudson JD, et al (1990) Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Circ Shock 32: 141–152PubMedGoogle Scholar
  18. 18.
    Rohrer MJ, Natale AM (1992) Effect of hypothermia on the coagulation cascade. Crit Care Med 20: 1402–1405PubMedCrossRefGoogle Scholar
  19. 19.
    Gubler KD, Gentillello LM, Hassantash SA, Maier RV (1994) The impact of hypothermia on dilutional coagulopathy. J Trauma 36: 847–851PubMedCrossRefGoogle Scholar
  20. 20.
    Reed RL, Johnson TD, Hudson JD, Fischer RP (1992) The disparity between hypothermic coagulopathy and clotting studies. J Trauma 33: 465–470PubMedCrossRefGoogle Scholar
  21. 21.
    Johnston TD, Chen Y, Reed RL (1994) Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma 37: 413–417PubMedCrossRefGoogle Scholar
  22. 22.
    Yoshihara H, Yamamoto T, Mihara H (1985) Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res 37: 503–512PubMedCrossRefGoogle Scholar
  23. 23.
    Yenari MA, Palmer JT, Bracci PM, Steinberg GK (1995) Thrombolysis with tissue plasminogen activator (tPA) is temperature dependent. Thromb Res 77: 475–481PubMedCrossRefGoogle Scholar
  24. 24.
    Gentilello LM, Pierson DJ (2001) Trauma critical care. Am J Respir Crit Care Med 163: 604607Google Scholar
  25. 25.
    Reed RL II, Ciavarella D, Heimbach DM, et al (1986) Prophylactic platelet administration during massive transfusion: a prospective, randomized, double-blind clinical study. Ann Surg 203: 40–48PubMedCrossRefGoogle Scholar
  26. 26.
    Harke H, Rahman S (1980) Haemostatic disorders in massive transfusion. Bibl Haematol 46: 179–188PubMedGoogle Scholar
  27. 27.
    Goodnight SH, Kenoyer G, Rapoport ST, et al (1974) Defibrination after brain tissue destruction. N Engl J Med 290: 1043–1047PubMedCrossRefGoogle Scholar
  28. 28.
    Rotondo MF, Reilly PM (2000) Bleeding and coagulation complications. In: Mattox KL, Feliciano DV, Moore EE (eds) Trauma. Fourth Edition. McGraw-Hill, New York, pp 1274–1275Google Scholar
  29. 29.
    Rohrer M, Natala A (1992) Effect of hypothermia on the coagulation cascade. Crit Care Med 20: 1402–1405PubMedCrossRefGoogle Scholar
  30. 30.
    Chandler W (1995) The thromboelastograph and the thromboelastograph technique. Semin Thromb Hemost 21 (suppl 4): 1–6PubMedGoogle Scholar
  31. 31.
    Spiess BD (1995) Perioperative coagulation monitoring. In: Spiess BD, Counts RB, Gould SA (eds) Perioperative Transfusion Medicine, 1st ed. Williams and Wilkins, Baltimore, pp 250–254Google Scholar
  32. 32.
    Kaufmann CR, Dwyer KM, Crews JD, et al (1997) Usefulness of thromboelastography in assessment of trauma patient coagulation. J Trauma 42: 716–720PubMedCrossRefGoogle Scholar
  33. 33.
    Peng RY, Bongard FS (1999) Hypothermia in trauma patients. J Am Coll Surg 188: 685–696PubMedCrossRefGoogle Scholar
  34. 34.
    Bernstein DE, Jeffers L, Erhardtsen E, et al (1997) Recombinant factor VIIa corrects pro-thrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113: 1930–1937PubMedCrossRefGoogle Scholar
  35. 35.
    Hender U, Ignerslev J (1998) Clinical use of recombinant FVIIa. Trans Sci 19: 163–176CrossRefGoogle Scholar
  36. 36.
    Arkin S, Cooper HA, Hutter JJ, et al (1998) Activaited recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophylia A and B with inhibitors: results of Novoseven emergency use program. Hemostasis 28: 93–98Google Scholar
  37. 37.
    Poon MC, Demers C, Jobin F, et al (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastenia. Blood 94: 3951–3953PubMedGoogle Scholar
  38. 38.
    Martinowitz U, Kenet G, Segal E, et al (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51: 431–439PubMedCrossRefGoogle Scholar
  39. 39.
    Lynn M, Jeroukhimov I, Jewelewicz D, et al (2002) Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock — a pilot study. J Trauma (in press)Google Scholar
  40. 40.
    Martinowitz U, Holcomb JB, Pusateri AE (2001) Intravenous rFVII administrated for hemorrhage control in hypothermic coagulopathic swine with grade V liver injury. J Trauma 50: 721–729PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • M. Lynn
  • I. Jeroukhimov
  • Y. Klein

There are no affiliations available

Personalised recommendations